USFDA nod may boost Unichem Laboratories

| Updated on September 20, 2019


Unichem Laboratories on Friday said inspection of its unit in Kolhapur, Maharashtra, by the US health regulator has been completed without any observations. The company’s newly-commissioned active pharmaceutical ingredients (API) facility was inspected by the United States Food and Drug Administration from September 16 to 20, Unichem Labs said. The CGMP surveillance and pre-approval inspection was successfully concluded without issue of Form 483, it added.

Published on September 21, 2019

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor

You May Also Like